Viewing Study NCT00532818

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-02-09 @ 1:41 AM
Study NCT ID: NCT00532818
Status: UNKNOWN
Last Update Posted: 2009-03-30
First Post: 2007-09-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Hydralazine Valproate for Cervical Cancer
Sponsor: National Institute of Cancerología
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Cervical Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epigenetic therapy View
None Hydralazine View
None Valproate View
None Cervical cancer View
None Randomized View
None Phase III View